Hyperion Therapeutics Inc (NASDAQ:HPTX)

45.97
Delayed Data
As of Apr 24
 -0.11 / -0.24%
Today’s Change
20.23
Today|||52-Week Range
46.96
+91.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.0042.2M113.6M
 
 
 
Cost of Goods Sold0.000.006.7M13.2M
 
 
 
Depreciation And Amortization69.0K15.0K3.3M5.1M
 
 
 
 
 
 
Operating ExpensesGross Income-69.0K-15.0K32.2M95.2M
 
 
 
 
 
General Expenses26.1M28.5M45.6M69.2M
 
 
 
 
 
Research And Development17.2M17.0M9.8M20.7M
 
 
 
 
 
Total Operating Expenses26.2M28.5M55.6M87.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.2M-28.5M-13.4M26.0M
 
 
 
 
 
Extraordinary Credit0.000.0031.1M--
 
 
Extraordinary Charge0.00-43.0K---30.8M
 
 
 
Interest Expense On Debt0.003.7M1.5M1.0M
 
 
 
 
Other Expenses0.004.0K526.0K-699.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.1M-32.3M16.7M-6.0M
 
 
 
 
 
Income Taxes0.000.00-49.0K-303.0K
 
 
 
Net Income-26.1M-32.3M16.6M-6.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.8M7.3M19.4M20.5M
 
 
 
 
 
Shares To Calculate EPS Diluted8.8M7.3M20.7M20.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.98-$4.45$0.80-$0.31
 
 
 
 
 
EPS Diluted-$2.98-$4.45$0.80-$0.31
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account